Back

DuPont invests $150 million in key growth markets for ethylene copolymers

2:90 min Facts & Figures
Wilmington, Del., USA

DuPont today announced that it is investing approximately $150 million to expand and upgrade manufacturing facilities in Europe, the United States and Asia to meet strong demand for its specialty ethylene copolymers in photovoltaics, packaging and automotive markets, as well as for new infrastructure in emerging economies.This investment will result in over 200 million pounds of additional capacity, enhanced capability of our current facilities, and reduced energy consumption of our operations,” said William F. Weber, global director, DuPont Ethylene Copolymers. “Importantly, it will accelerate DuPont’s ability to respond to rapidly growing demand as we serve our customers worldwide.”Newly announced investments include: Added capacity at Dordrecht, the Netherlands, to expand the global operations network for DuPont™ Fusabond® modifiers and DuPont™ Bynel® adhesive resins and to serve the European market. The new capacity is expected to be online in 2009. Enhanced capabilities for DuPont™ Surlyn® ionomer resin and Vamac® ethylene acrylic elastomers from DuPont Performance Elastomers and upgrades to improve energy efficiency at DuPont’s Sabine operation in Orange, Tex. These will be operational in 2008 and 2009. Production efficiency investments at the Victoria, Tex., facility for DuPont™ Elvax® ethlyene vinyl acetate copolymer (EVA) products. These will be operational in 2008 and 2009. As previously announced, DuPont will construct an EVA facility near Beijing, China, with its joint venture partner, Sinopec. The facility, the first EVA manufacturing operation for DuPont in China, will supply a broad range of EVA products, thus strengthening DuPont’s position in the world’s fastest growing EVA market. The facility will begin operations in 2009.

 

Cathy Branciaroli

+1 302-792-4349

DuPont today announced that it is investing approximately $150 million to expand and upgrade manufacturing facilities in Europe, the United States and Asia to meet strong demand for its specialty ethylene copolymers in photovoltaics, packaging and automotive markets, as well as for new infrastructure in emerging economies.

This investment will result in over 200 million pounds of additional capacity, enhanced capability of our current facilities, and reduced energy consumption of our operations,” said William F. Weber, global director, DuPont Ethylene Copolymers. “Importantly, it will accelerate DuPont’s ability to respond to rapidly growing demand as we serve our customers worldwide.”

Newly announced investments include:

  • Added capacity at Dordrecht, the Netherlands, to expand the global operations network for DuPont™ Fusabond® modifiers and DuPont™ Bynel® adhesive resins and to serve the European market. The new capacity is expected to be online in 2009.
  • Enhanced capabilities for DuPont™ Surlyn® ionomer resin and Vamac® ethylene acrylic elastomers from DuPont Performance Elastomers and upgrades to improve energy efficiency at DuPont’s Sabine operation in Orange, Tex. These will be operational in 2008 and 2009.
  • Production efficiency investments at the Victoria, Tex., facility for DuPont™ Elvax® ethlyene vinyl acetate copolymer (EVA) products. These will be operational in 2008 and 2009.

As previously announced, DuPont will construct an EVA facility near Beijing, China, with its joint venture partner, Sinopec. The facility, the first EVA manufacturing operation for DuPont in China, will supply a broad range of EVA products, thus strengthening DuPont’s position in the world’s fastest growing EVA market. The facility will begin operations in 2009.


Cathy Branciaroli
+1 302-792-4349
PETnology's Resource Guide
comPETence center

The comPETence center provides your organisation with a dynamic, cost effective way to promote your products and services.

Find out more

Cover
Our premium articles
comPETence
magazine

Find our premium articles, interviews, reports and more
in 3 issues in 2023.

Find out more
Current issue